|
August 30, 2005 - Volume 5 Added :
Dow Chlorophenol Dioxin Serum Levels
FLAWED SCIENCE
The
effects of dioxin exposure on human health have been studied
for almost fifty years. The Dow Chemical Company is a
recognized leader in the various issues associated with
dioxin exposure to chemical workers and residential
neighbors.
DioxinSpin is
confident that The Dow Chemical Company would like to
present the most accurate, scientifically sound information
needed by all the parties affected by dioxin contamination in the
Midland plant, in the city of Midland and in the Saginaw
Valley.
However, even Dow, with all its
resources and expertise, can make a mistake a defect that brings into
question the validity of a single study or, perhaps, even
the validity of several studies.
Until any defects are
corrected or found to be inconsequential, the relevant study
(or studies) must be considered flawed
science.
This section of DioxinSpin.com will
address various defects and oversights that appear to be
present in mortality and environmental studies that the
company has published or provided to the DEQ/EPA.
A copy of each analysis will be
sent to the company for review and, hopefully, comment.
Responses made by the company will be presented in this
section, as received without revision.
VOLUME 1 (link)
: This volume
focuses on potential mistakes that the company may have made
in mortality studies of Midland plant employees exposed to
pesticide plant dioxins. Discrepancies have been found
in the following areas:
(1) Total number of employees exposed to pesticide dioxins
(2) Total number of
employees that worked in each pesticide plant
(3) Number of
employees exposed to varying intensities of TCDD
VOLUME 2 (link)
:
This volume focuses on potential errors that the company may
have made in the most recent mortality studies of dioxin
exposed Midland plant workers. Errors may be present
in the following areas:
(1) Unexpected decline in the number of expected
deaths
(2) Unrecognized
higher mortality in non-chloracne workers
(3) Unrecognized
higher mortality in workers exposed to TCDD
VOLUME 3
(link) : This volumes
addresses potential defects in one of the company's 2005
studies of dioxin levels in the Tittabawassee River.
The number of defects are sufficient to severely limit the
value of the study.
Link to DEQ website and Dow
dioxin studies:
http://www.michigan.gov/deq/0,1607,7-135-3312_4118_4240-53424--,00.html
Direct link to DioxinSpin.com
file copy of study :
Link
VOLUME 4 (link)
:
Dow Chemical and Michigan
Department of Community Heath studies of
dioxin blood serum levels in Midland area residents and Dow
employees reference a ATSDR-CDC study, Patterson, et al,
2004, that provides an estimate of background blood
serum levels in 588 U.S. citizens supposedly not exposed to
dioxins other than in their diet or in an environment
distant from known sources of dioxins.
However, Patterson,
failed to exclude four unusually high serum levels and, as a
result, the reported ranges of dioxin levels by age group
are much greater than if only the 584 more normal levels
were used. As a result, some of the dioxin serum
studies being carried out in Michigan erroneously report
that ranges of serum levels being found are "lower
than" or "are consistent" with US background levels.
In addition, the Dow and MDCH
studies determined dioxin serum levels in the
test subjects in 2004 and 2005. However, Patterson
was based on serum levels measured in 1996, 1997 and 2001.
The Dow and MDCH studies failed to adjust the Patterson
serum levels to 2004/2005 levels which would be reduced
through biological degradation.
More information on these topics
can be found in Recalculation of U.S. Background Dioxin
Blood Serum Levels via the Volume 4 (link).
Link to Patterson, et al, :
Patterson study
VOLUME 5 (link)
:
In September, 2003, The Dow
Chemical Company measured dioxin blood serum levels in a
small number of its chlorophenol employees that were exposed
to dioxins and furans present in certain pesticide plants.
Following a release of partial
results to the media and the DEQ in 2004 and 2005, the full
study was made available in July, 2005.
The study has been criticized by
some regulatory agencies. Dow has taken the unusual
step of having the principle peer-reviewer of the study
publicly praise the its epidemiological professionalism and
the study itself in a local newspaper. The company
recently defended the study in a "letter to editor" in
another local newspaper.
The study may contain a number
of potential defects such as selection bias that brings
into question the validity of some portions of the study. An
analysis of the study can be viewed by linking to the
Volume 5 (link)
The Dow Chlorophenol study can
be viewed via
Link
to Dow Chlorophenol Study
:
(The study is being made available to DioxinSpin.com readers
under the Fair Use provisions of US Copyright laws and is
subject to the provisions thereof)
DOW CHEMICAL
RESPONSE : None received
to date.

|